Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on January 26, 2022. The report addresses corporate governance events regarding the Company's Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a procedural corporate event and contains no financial performance data.
Material Changes
The primary event reported is the failure to achieve a quorum at the reconvened Annual Meeting of Shareholders held on January 25, 2022. Consequently, the meeting was adjourned again.
Outlook, Management Commentary, and Risks
- Meeting Adjournment: The Annual Meeting has been rescheduled to February 25, 2022, at 4:00 p.m. Eastern Time.
- Location: The reconvened meeting will be held at the offices of Shumaker, Loop, & Kendrick in Tampa, FL.
- Record Date: The record date remains October 1, 2021.
- Voting Proposals: No changes have been made to the proposals to be voted on by shareholders.
- Shareholder Action: Shareholders who have already voted do not need to take further action unless they wish to change their vote.
Key Facts for Investor Verification
- Verify the outcome of the Annual Meeting scheduled for February 25, 2022.
- Review the definitive proxy statement (Schedule 14A) filed on October 13, 2021, for details on the specific proposals pending a vote.
- Monitor future filings for the results of the shareholder vote and any potential impact on corporate governance or board composition.